Literature DB >> 6277800

Heterotransplantation of small-cell carcinoma of the lung into nude mice: comparison of intracranial and subcutaneous routes.

A F Gazdar, D N Carney, H L Sims, A Simmons.   

Abstract

We compared and contrasted intracranial (i.c.) and subcutaneous (s.c.) heterotransplantation of small-cell carcinoma of the lung (SCCL) into athymic nude mice. Fresh human SCCL tumor specimens, tumor colonies grown in soft agarose and continuous cell lines were used. Tumors induced by the three types of specimens were similar, but s.c. and i.c. transplants differed. S.c. tumors had longer latent times, were non-invasive and non-lethal. I.c. tumors has shorter latent periods, invariably grew in the meninges, frequently invaded and destroyed the underlying brain, and were lethal. The tumor-inducing dose for i.c. transplantation was 10 to 1,000 times lower than for s.c. transplantation. Pooled colonies of SCCL tumor specimens grown in soft agarose were inoculated i.c. While they contained relatively small numbers of cells (400-10,000), 83% of these colony specimens induced tumors after 58-243 days, confirming the "stem-cell" origin of the colonies. I.c. and s.c. transplants retained the characteristic morphology of SCCL, and, with one exception, did not metastasize to distant organs. Continuous cell lines could be established readily from both types of transplants, and they retained the characteristic cytology, growth and biochemical properties of the original SCCL tumors. I.c. heterotransplantation of SCCL is a useful tool, especially when small numbers of tumor cells are available, and may provide a model to study the biology and therapy of meningeal carcinomatosis.

Entities:  

Mesh:

Year:  1981        PMID: 6277800     DOI: 10.1002/ijc.2910280617

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Inhibition of tumor growth and angiogenesis by a lysophosphatidic acid antagonist in an engineered three-dimensional lung cancer xenograft model.

Authors:  Xiaoyu Xu; Glenn D Prestwich
Journal:  Cancer       Date:  2010-04-01       Impact factor: 6.860

Review 2.  Lung cancer cell lines as tools for biomedical discovery and research.

Authors:  Adi F Gazdar; Luc Girard; William W Lockwood; Wan L Lam; John D Minna
Journal:  J Natl Cancer Inst       Date:  2010-08-02       Impact factor: 13.506

Review 3.  Studying lung cancer in the laboratory: 1--Development of model systems.

Authors:  R J Fergusson; J F Smyth
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

Review 4.  Human tumor xenografts as model for drug testing.

Authors:  J Mattern; M Bak; E W Hahn; M Volm
Journal:  Cancer Metastasis Rev       Date:  1988-11       Impact factor: 9.264

Review 5.  From Mice to Men and Back: An Assessment of Preclinical Model Systems for the Study of Lung Cancers.

Authors:  Adi F Gazdar; Fred R Hirsch; John D Minna
Journal:  J Thorac Oncol       Date:  2015-12-24       Impact factor: 15.609

6.  Correlative effect between in vivo hollow fiber assay and xenografts assay in drug screening.

Authors:  Keyong Ho Lee; Ki Hyeong Rhee
Journal:  Cancer Res Treat       Date:  2005-06-30       Impact factor: 4.679

Review 7.  Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy.

Authors:  James P Sullivan; John D Minna; Jerry W Shay
Journal:  Cancer Metastasis Rev       Date:  2010-03       Impact factor: 9.264

Review 8.  Small-cell lung cancer: what we know, what we need to know and the path forward.

Authors:  Adi F Gazdar; Paul A Bunn; John D Minna
Journal:  Nat Rev Cancer       Date:  2017-10-27       Impact factor: 60.716

Review 9.  Evaluating dual activity LPA receptor pan-antagonist/autotaxin inhibitors as anti-cancer agents in vivo using engineered human tumors.

Authors:  Xiaoyu Xu; Guanghui Yang; Honglu Zhang; Glenn D Prestwich
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-08-12       Impact factor: 3.072

Review 10.  Importance of orthotopic implantation for human tumors as model systems: relevance to metastasis and invasion.

Authors:  C Manzotti; R A Audisio; G Pratesi
Journal:  Clin Exp Metastasis       Date:  1993-01       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.